Drug Trial Radar · NCT01290445
Varenicline Pregnancy Cohort Study
Last checked: Nov 19, 2026Latest source record: Jul 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
885,185
Actual
Start
Sep 13, 2007
Primary completion
May 1, 2016
Study completion May 1, 2016
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- Collaborators
- University of Aarhus; Karolinska Institutet
- First posted
- Feb 7, 2011
Design
- Study type
- Observational
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective population-based cohort study to examine whether varenicline use during pregnancy is associated with an increased risk of major congenital malformations in infants above that associated with smoking during pregnancy.
Conditions
- Malformations
Interventions
vareniclineDrug
This is a non-interventional study. Exposure in utero to varenicline is observed, not assigned.
cigarette smoke from maternal smokingBehavioral
This is a non-interventional study. Exposure in utero to cigarette smoke from maternal smoking is observed, not assigned.
Non-ExposureOther
This is a non-interventional study. Non-exposure in utero to varenicline and cigarette smoke from maternal smoking is observed, not assigned.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Infants With Major Congenital MalformationsTime frame: For 12 months after birth
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.